Status: Recruiting
Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults
This clinical trial aims to evaluate the efficacy and safety of AMOR-1, consisting of Amorphous Calcium Carbonate (ACC) as the active drug substance, in treating hypocalcemia in adults with hypoparathyroidism.
Participants needed: 81
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Amorphical Ltd.Updated: Sep 4, 2025Locations: 8
Eligibility criteria
An understanding, ability, and willingness to fully comply with study procedures... [+11]
Any disease that might affect calcium metabolism or calcium-phosphate homeostasi... [+18]